Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience

被引:32
|
作者
Moscarella, Elisabetta [1 ,2 ]
Varricchio, Attilio [1 ]
Stabile, Eugenio [3 ]
Latib, Azeem [4 ,5 ]
Ielasi, Alfonso [6 ]
Tespili, Maurizio [6 ]
Cortese, Bernardo [7 ]
Calabro, Paolo [2 ]
Granata, Francesco [1 ,2 ]
Panoulas, Vasileios F. [5 ]
Franzone, Anna [3 ]
Trimarco, Bruno [3 ]
Bonzani, Giulio [1 ]
Esposito, Giovanni [3 ]
Colombo, Antonio [4 ,5 ]
机构
[1] Azienda Osped Dei Colli, Presidio Osped Monaldi, Dept Cardiol, Lab Invas Cardiol, Naples, Italy
[2] Univ Naples 2, Azienda Osped Dei Colli, Presidio Osped Monaldi, Lab Invas Cardiol,Dept Cardiol, Naples, Italy
[3] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Lab Invas Cardiol, Naples, Italy
[4] EMO GVM Ctr Cuore Columbus, UO Emodinam & Cardiol Interventist, Milan, Italy
[5] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy
[6] UOC Cardiol, Azienda Osped Bolognini Seriate, Bergamo, Italy
[7] Azienda Osped Fatebenefratelli, Lab Invas Cardiol, Milan, Italy
关键词
BVS; Restenosis; DES; Stent; DRUG-ELUTING STENTS; BALLOON ANGIOPLASTY; RANDOMIZED-TRIAL;
D O I
10.1016/j.ijcard.2015.07.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:366 / 372
页数:7
相关论文
共 50 条
  • [31] Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report
    Giordano, Arturo
    Ferraro, Paolo
    Corcione, Nicola
    Messina, Stefano
    Maresca, Gennaro
    Coscioni, Enrico
    Biondi-Zoccai, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2016, 21 : 78 - 82
  • [32] Treatment of Coronary In-Stent Restenosis With Bioabsorbable Vascular Scaffolds
    Alfonso, Fernando
    Nuccio, Julio
    Cuevas, Cecilia
    Cardenas, Alberto
    Gonzalo, Nieves
    Jimenez-Quevedo, Pilar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (25) : 2875 - 2875
  • [33] Rotational Atherectomy Combined With Bioresorbable Vascular Scaffold Implantation: A Feasible Approach for Recurrent In-stent Restenosis When Other Therapies Failed
    Pereira-da-Silva, Tiago
    Patricio, Lino
    Ferreira, Rui Cruz
    [J]. JOURNAL OF INVASIVE CARDIOLOGY, 2015, 27 (07): : E143 - E145
  • [34] Treatment of In-Stent Restenosis With Bioresorbable Vascular Scaffolds: Optical Coherence Tomography Insights
    Rivero, Fernando
    Bastante, Teresa
    Cuesta, Javier
    Benedicto, Amparo
    Restrepo, Jorge A.
    Alfonso, Fernando
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (03) : 255 - 259
  • [35] Restenosis after coronary spasm in a bioresorbable vascular scaffold
    Dalos, Daniel
    Vertesich, Markus
    Jakowitsch, Johannes
    Lang, Irene M.
    [J]. CORONARY ARTERY DISEASE, 2016, 27 (02) : 159 - 161
  • [36] EXPERIENCE TREATING IN-STENT RESTENOSIS LESIONS FROM A MULTICENTER REGISTRY
    Banerjee, Subhash
    Sarode, Karan
    Mohammad, Atif
    Gigliotti, Osvaldo
    Luna, Michael
    Addo, Tayo
    Baig, Mirza
    Tsai, Shirling
    Shammas, Nicolas
    Prasad, Anand
    Abu-Fadel, Mazen
    Klein, Andrew
    Brilakis, Emmanouil
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1845 - A1845
  • [37] Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry
    Moscarella, Elisabetta
    Varricchio, Attilio
    Stabile, Eugenio
    Franzone, Anna
    Granata, Francesco
    Rapacciuolo, Antonio
    Galasso, Gennaro
    Capozzolo, Claudia
    Cirillo, Plinio
    Monda, Vittorio
    Monterforte, Ida
    Borgia, Francesco
    Piro, Orlando
    Bonzani, Giulio
    Trimarco, Bruno
    Esposito, Giovanni
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2015, 16 (07) : 401 - 405
  • [38] Bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the Italian multicenter RAI Registry
    Masiero, Giulia
    Tarantini, Giuseppe
    Mojoli, Marco
    Loi, Bruno
    Cortese, Bernardo
    Varricchio, Attilio
    Ielasi, Alfonso
    Pisano, Francesco
    Mazzarotto, Pietro
    Calabro', Paolo
    Gistri, Roberto
    Durante, Alessandro
    Piraino, Davide
    Tumminello, Gabriele
    Lucci, Valerio
    Moretti, Luciano
    Misuraca, Leonardo
    Pasquetto, Giampaolo
    Colombo, Alessandro
    Ferrario, Maurizio
    Coscarelli, Sebastian
    Olivari, Zoran
    Nicolino, Annamaria
    Piatti, Luigi
    Tellaroli, Paola
    Corrado, Donatella
    Steffenino, Giuseppe
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B171 - B172
  • [39] Coronary In-Stent Restenosis: Predictors and Treatment
    Ullrich, Helen
    Olschewski, Maximilian
    Muenzel, Thomas
    Gori, Tommaso
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 118 (38): : 637 - +
  • [40] In-stent restenosis treated with everolimus-eluting bioresorbable scaffold: 1-year angiographic results
    Gomez-Blazquez, Ivan
    Jimenez Diaz, Victor
    Fernandez-Barbeira, Saleta
    Bastos Fernandez, Guillermo
    De Miguel Castro, Antonio
    Baz Alonso, Jose Antonio
    Ortiz, Alberto
    Iniguez, Andres
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B343 - B343